Literature DB >> 11746050

Molybdopterin synthase mutations in a mild case of molybdenum cofactor deficiency.

J L Johnson1, K E Coyne, K V Rajagopalan, J L Van Hove, M Mackay, J Pitt, A Boneh.   

Abstract

Molybdenum cofactor deficiency is a rare inborn error of metabolism with generally severe symptoms, most often including neonatal seizures and severe developmental delay. We describe a patient with an unusually mild form of the disease. Two mutations in MOCS2A (molybdenum cofactor synthesis enzyme 2A) were identified: a single base change, 16C > T, that predicts a Q6X substitution on one allele and a 19G > T transversion that predicts a valine to phenylalanine substitution, V7F, on the second. It is postulated that the milder clinical symptoms result from a low level of residual molybdopterin synthase activity derived from the 19G > T allele. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746050     DOI: 10.1002/1096-8628(20011122)104:2<169::aid-ajmg1603>3.0.co;2-8

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Ten novel mutations in the molybdenum cofactor genes MOCS1 and MOCS2 and in vitro characterization of a MOCS2 mutation that abolishes the binding ability of molybdopterin synthase.

Authors:  Silke Leimkühler; Mathilde Charcosset; Philippe Latour; Claude Dorche; Soledad Kleppe; Fernando Scaglia; Irmina Szymczak; Petra Schupp; Rita Hahnewald; Jochen Reiss
Journal:  Hum Genet       Date:  2005-07-14       Impact factor: 4.132

2.  Delineating the phenotypic spectrum of sulfite oxidase and molybdenum cofactor deficiency.

Authors:  Albert L Misko; Ye Liang; Joshua B Kohl; Florian Eichler
Journal:  Neurol Genet       Date:  2020-07-14

3.  Ocular characteristics of a 6-year-Old boy with molybdenum cofactor deficiency type B.

Authors:  Wenjia Yan; Li Huang; Limei Sun; Xiaoyan Ding
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-14

4.  Mouse model for molybdenum cofactor deficiency type B recapitulates the phenotype observed in molybdenum cofactor deficient patients.

Authors:  Joanna Jakubiczka-Smorag; Jose Angel Santamaria-Araujo; Imke Metz; Avadh Kumar; Samy Hakroush; Wolfgang Brueck; Guenter Schwarz; Peter Burfeind; Jochen Reiss; Lukasz Smorag
Journal:  Hum Genet       Date:  2016-05-02       Impact factor: 4.132

Review 5.  Sulfite oxidizing enzymes.

Authors:  Changjian Feng; Gordon Tollin; John H Enemark
Journal:  Biochim Biophys Acta       Date:  2007-03-20

6.  Mild phenotype in Molybdenum cofactor deficiency: A new patient and review of the literature.

Authors:  Barbara Scelsa; Serena Gasperini; Andrea Righini; Maria Iascone; Valeria G Brazzoduro; Pierangelo Veggiotti
Journal:  Mol Genet Genomic Med       Date:  2019-03-21       Impact factor: 2.183

7.  The effect of dietary protein restriction in a case of molybdenum cofactor deficiency with MOCS1 mutation.

Authors:  Yu Abe; Yu Aihara; Wakaba Endo; Hiroshi Hasegawa; Kimiyoshi Ichida; Mitsugu Uematsu; Shigeo Kure
Journal:  Mol Genet Metab Rep       Date:  2021-02-01

8.  moc-6/MOCS2A is necessary for molybdenum cofactor synthesis in C. elegans.

Authors:  Jennifer Snoozy; Peter C Breen; Gary Ruvkun; Kurt Warnhoff
Journal:  MicroPubl Biol       Date:  2022-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.